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Introduction: Placental vascularity may be important in the development of fetal growth restriction
(FGR). The overnourished adolescent ewe is a robust model of the condition, with ~50% of offspring
demonstrating FGR (birthweight >2 standard deviations below optimally-fed control mean). We studied
whether placental vascularity, angiogenesis and glucose transport reﬂect FGR severity.
Methods: Singleton pregnancies were established in adolescent ewes either overnourished to putatively
restrict fetoplacental growth (n ¼ 27) or control-fed (n ¼ 12). At 131d (term ¼ 145d) pregnancies were
interrupted and fetuses classiﬁed as FGR (n ¼ 17, <4222 g, -2SD below control-fed mean) or non-FGR
(n ¼ 10). Placentome capillary area density (CAD), number density (CND), surface density (CSD), and
area per capillary (APC) in the fetal cotyledon (COT) and maternal caruncle (CAR) were analysed using
immunostaining. COT/CAR mRNA expression of angiogenic ligands/receptors and glucose transporters
were measured by qRT-PCR.
Results: Fetal weight was reduced in FGR vs. Non-FGR/Control groups. Total placentome weight was
Control > Non-FGR > FGR and fetal:placental weight ratios were higher in overnourished versus Control
groups. COT vascular indices were Non-FGR > FGR > Control. COT-CAD, CSD and APC were signiﬁcantly
greater in Non-FGR overnourished versus Control and intermediate in FGR groups. CAR vascularity did
not differ. CAR-VEGFA/FLT1/KDR/ANGPT1/ANGPT2/SLC2A1/SLC2A3 mRNA was lower and COT-ANGPT2
higher in overnourished versus Control groups.
Discussion: Relative to control-intake pregnancy, overnourished pregnancies are characterised by higher
COT vascularity, potentially a compensatory response to reduced nutrient supply, reﬂected by higher
fetal:placental weight ratios. Compared with overnourished pregnancies where fetal growth is relatively
preserved, overnourished pregnancies culminating in marked FGR have less placental vascularity, sug-
gesting incomplete adaptation to the prenatal insult.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Fetal growth restriction (FGR), wherein the fetus fails to achieve
its growth potential, remains a leading cause of perinatal morbidity
andmortality [1]. The most common cause of FGR is uteroplacental
insufﬁciency, in which delivery of oxygen/nutrients to the fetus
is limited [2]. The sheep is widely used to model placentalk University School of Medi-
r).
r Ltd. This is an open access articleinsufﬁciency through premating carunclectomy, placental embo-
lisation, single umbilical artery ligation and maternal hyperther-
mia, which all adversely impact placental weight/function [3]. FGR
may also be induced by overnourishing pregnant adolescent ewes
[4]; high dietary intakes in still-growing dams promote nutrient
partitioning to maternal tissues, away from the fetoplacental unit,
resulting in FGR compared with control-fed adolescent dams.
Accordingly, the greater the anabolic drive in the young mother,
the greater the birth weight reduction in her offspring; this is
highlighted by the fact that maternal gestational weight gain (g/
day) in the ﬁrst third of pregnancy is inversely related to the degree
of FGR [5].under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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placental weight correlates strongly with late-gestation fetal
weight and lamb birthweight across studies [5] and although
placental weight per se is not impacted until ~d100 (term ¼ 145d),
early stigmata of placental dysfunction are evident. Capillary den-
sity in the fetal cotyledon (COT) is lower at d50 [6] and mRNA
expression of ﬁve angiogenic ligands/receptors is attenuated in d81
placentomes [7]. Placental cellular proliferation is lower and
secretory function (e.g. placental lactogen) impaired [8e10]. Serial
assessments of uterine blood ﬂow (UBF) and ultrasound markers of
placental size reveal reductions in overnourished pregnancies from
mid-pregnancy onwards [11,12]. By the ﬁnal third of gestation,
placental weight is signiﬁcantly lower, mirrored by reductions in
placental glucose transport and fetal nutrient uptakes, ultimately
constraining fetal growth [13].
However, not all fetuses of overnourished adolescent dams are
markedly growth-restricted at term; historically, only ~50% of
offspring of overnourishedmothers have a birthweight>2SD below
the mean birthweight of normally-grown controls. The remainder
exhibit relatively “normal” birthweight despite equivalent
maternal nutritional manipulation and signiﬁcant shifts in
placental weight relative to control-fed dams and are considered
“non-FGR”. We hypothesised that differences in placental vascular
indices and/or expression of key angiogenic ligands/receptors exist
between FGR and non-FGR overnourished pregnancies, and may
explain the apparent reserve capacity of the placenta, which
maintains adequate fetal growth in a proportion of overnourished
pregnancies despite early placental insults.
2. Materials and methods
2.1. Experimental animals and study design
Animal procedures were approved and regulated by the UK
Home Ofﬁce (Animals (Scientiﬁc Procedures) Act 1986) and local
ethics committee review. Ewes were housed in individual pens





W). Singleton pregnancies with maximum genetic homogeneity
were generated using superovulation and laparoscopic intrauterine
insemination in donor adult ewes, and embryo transfer into
recipient adolescent ewe lambs, as described [14]. Immediately
following embryo transfer and throughout pregnancy, ewes were
fed a control ration to support normal fetoplacental development
(n¼ 12) or a high intake to potentially restrict fetoplacental growth
(n ¼ 27), as described [15].
2.2. Ultrasound assessment
At d126 ± 0.3 ewes underwent detailed ultrasound examination
including fetal biometry [16]: abdominal circumference (AC), renal
volume (RV), biparietal diameter (BPD), tibial length (TL) and femur
length (FL). Placentome index was calculated (sum of individual
cross-sectional areas of ten representative placentomes). Umbilical
cord diameter (UCD) was measured close to the abdominal inser-
tion. Umbilical artery (UA) pulsatility index (PI), resistance index
(RI) and systolic:diastolic ratio (SDR) were measured using Doppler
waveform analysis [12].
2.3. Necropsy and tissue sampling
At d131 ± 0.3, maternal plasma was sampled for the subsequent
measurement of metabolic parameters (see below), then ewes
were killed by intravenous pentobarbital sodium overdose
(200 mg/ml). Fetuses were delivered by hysterotomy and eutha-
nased (same method) before being dried/weighed. The placentaoccupied the gravid and non-gravid uterine horn in all cases and
placentomes representative of average size and gross morphology
(based on the classiﬁcation system of Vatnick et al. [17]) were
sampled from the lower third of the non-gravid horn. A group of six
placentomes were weighed, and a size and morphology category
attributed: four placentomes were separated into COT and
maternal caruncular (CAR) components by gentle traction, snap-
frozen in isopentane chilled with liquid nitrogen and stored
at 80 C, and two whole placentomes were sliced into 5 mm
cross-sections, immersion-ﬁxed in Carnoy's solution and prepared
for immunoﬂuorescence analysis, as described [18,19]. Remaining
placentomes were dissected, weighed and a size and morphology
category attributed. On this basis it was established whether the
placentomes rapidly selected for snap-freezing/histology were
representative of the entire placenta. For 35 of 39 pregnancies the
sampled placentomes were entirely representative of the most
prevalent gross morphology category observed in the individual.
For the remaining four animals, the sampled placentomes were
representative by mass but not number because they were very
large. Thus, three animals had D type placentomes sampled (all
controls) and one had C type placentomes sampled (non-FGR). The
total placentome weight was added to the membrane weight to
give the total placental weight.
2.4. Metabolic parameters
Plasma glucose levels were determined in maternal blood
samples using a dual biochemistry analyser (Model 2700, Yellow
Springs Instruments, Yellow Springs, OH, USA) and variation be-
tween duplicates was <5%. Plasma insulin and insulin-like growth
factor (IGF)-1 levels were determined using double antibody ra-
dioimmunoassays, as previously described [20,21]. The limits of
sensitivity for the insulin and IGF1 assays were 0.08 and 0.04 ng/ml,
respectively, and the intra- and inter-assay coefﬁcients of variation
were both <10%.
3. Quantitative RT-PCR
RNA was extracted from separately-frozen COT/CAR tissues and
subjected to qRT-PCR for nine angiogenic ligands/receptors and
two glucose transporters using ovine-speciﬁc Taqman probes/
primers, as described [7,22]: VEGFA, FGF2, NOS3, ANGPT1, ANGPT2,
FLT1, KDR, TEK, GUCY1, SLC2A1 and SLC2A3. mRNA expression for
each gene of interest was quantiﬁed using a standard curve based
on reference cDNA generated from RNA from pooled d131 pla-
centomes (representative of control and overnourished groups),
and normalised to 18S.
3.1. Assessment of placental vascularity/proliferation
Parafﬁn-embedded 5 mm placentome sections underwent
rehydration in ethanol, and antigen retrieval using 50 mM glycine,
1 mM EDTA and 0.05% Tween 20 (pH 9.0) at 120 C for 10 min.
Sections were incubated with anti-CD31 primary antibodies
(ab28364, Abcam, Cambridge, UK) and CF633 goat anti-rabbit IgG
secondary antibodies (20122, Biotium, Hayward, CA, USA) to
identify all blood vessels (maternal/fetal) by immunoﬂuorescent
labeling. The trophoblast layer was stained with 20 mg/ml FITC-
labeled BS1 lectin (FL-1101; Vector Laboratories, Burlingame CA,
USA) and proliferating cells were stained with anti-Ki67 mouse
monoclonal antibody (VP-k452, Vector Laboratories), as described
[18]. Cell nuclei were counterstained with DAPI (P36931, Life
Technologies) for total (nucleus) counts and proliferation reported
as percentage of Ki67 stained nuclei. Placental vascularity was
quantiﬁed, as described [18,23] and vascularity and cell
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one placentome per animal. Blood vessels were identiﬁed through
anti-CD31 immunoﬂuorescence. CAR/COT compartments were
identiﬁed based on speciﬁc lectin staining of fetal trophoblast and
individually circumscribed. Capillary number (per mm2), perimeter
(mm) and area (mm2) were determined, from which the following
vascular indices were calculated (separately in CAR/COT): capillary
area density, CAD (capillary area ÷ tissue area); capillary number
density, CND (capillary number ÷ tissue area); capillary surface
density, CSD (capillary perimeter ÷ tissue area); and area per
capillary, APC (capillary area ÷ capillary number). Representative
immunoﬂuorescence images (separately/overlaid) and analyses are
presented in Fig. 1 (Ki67 staining not shown).
3.2. Statistical analysis
Fetuses of overnourished damswere classiﬁed as FGR (n¼ 17) or
non-FGR (n¼ 10) according to an accepted deﬁnition (weight >2SD
below genetically-matched control mean [24]). The cut-off was
4222 g. Data were analysed in SPSS v19.0 (SPSS Inc, Chicago, IL,
USA). After conﬁrming normality and equality of variance using Q-
Q plots and Levene's test, respectively, the three groups (Control,
FGR and Non-FGR) were compared using one-way ANOVA and
post-hoc test of least signiﬁcant difference (LSD). The effect of
diet alone (control-intake vs. all overnourished) was assessed using
Student's t-test. Data are presented as mean ± standard error
(SEM). Statistical signiﬁcance was set at p < 0.05.
4. Results
4.1. Late gestation ultrasound assessment
Table 1 shows ultrasound ﬁndings at d126 ± 0.3. By this stage of
gestation, all fetal biometry was tracking signiﬁcantly smaller in
overnourished pregnancies subsequently deﬁned as FGR,
compared to control-intake pregnancies. Measurements of BPD, AC,
FL, TL and RV were larger in Control versus FGR groups
(p < 0.001e0.008) and intermediate in the Non-FGR group. For AC/
RV (most sensitive growth indices) and UCD, Non-FGR measure-
ments were smaller than controls (p¼<0.001/p ¼ 0.017/p ¼ 0.008)
but larger than the FGR group (p¼ 0.02/p¼ 0.037/p¼ 0.009). TL/FL
were also greater in Non-FGR versus FGR groups (p ¼ 0.001/
p ¼ 0.033). Placentome indices did not differ between FGR and
Non-FGR groups (p ¼ 0.366) but were smaller in both over-
nourished groups relative to controls (p < 0.001/p ¼ 0.014). Like-
wise, UA Doppler indices (PI/RI/SDR) were equivalent in FGR and
Non-FGR overnourished pregnancies (p > 0.05), and all were
higher relative to control-intake pregnancies (p < 0.001e0.005),
indicating higher impedance.
4.2. Pregnancy outcome
Table 2 shows pregnancy outcomes at d131 ± 0.3. By design, FGR
fetuses weighed less than Control and Non-FGR fetuses (28%/25%,
p < 0.001) whilst Control and Non-FGR groups did not differ. Total/
average placentome and total placental weights were reduced in
FGR and Non-FGR groups compared with controls
(p ¼ 0.002e0.01). Although placentome number was equivalent,
the total placentome/placental weight was attenuated in FGR
pregnancies compared with the two other groups (p < 0.01). The
proportion of placentomes ranging between 1 and 2 cm tended to
be signiﬁcantly greater in FGR versus Control groups (p ¼ 0.06).
Although therewere no statistically signiﬁcant differences between
the three groupswith respect to placentome type, therewas a trend
towards a greater proportion of A type and smaller proportion of Dtype placentomes in the FGR group (Fig. 2). The proportion of A
type placentomes was inversely correlated with CAR APC
(r¼0.415, n¼ 39, p¼ 0.015). Fetal:placental weight ratios did not
differ between overnourished subsets (p ¼ 0.618), but were greater
in FGR/Non-FGR groups versus controls (p ¼ 0.018/p ¼ 0.029).
Taking all overnourished pregnancies together, fetal:placental
weight ratios were greater than in control-intake pregnancies
(11.8 ± 0.43 vs. 9.9 ± 0.42, p ¼ 0.01). Fetal and total placental
weights correlated strongly in overnourished (r ¼ 0.787, n ¼ 27,
p < 0.001) but not control-intake (r ¼ 0.365, n ¼ 12, p ¼ 0.243)
pregnancies. With respect to maternal metabolic status, compared
to the Control group, mothers of FGR and Non-FGR overnourished
offspring demonstrated higher plasma levels of glucose (69.1 ± 1.52
and 69.9 ± 2.05 vs. 62.3 ± 1.44 mg/dl, respectively, p ¼ 0.006), in-
sulin (2.44 ± 0.173 and 1.79 ± 0.135 vs. 1.13 ± 0.157 ng/ml, respec-
tively, p < 0.001) and IGF1 (0.49 ± 0.023 and 0.41 ± 0.023 vs.
0.36 ± 0.0217 ng/ml, respectively, p ¼ 0.001).
4.3. Placental mRNA expression
Table 3 shows expression of angiogenic ligands/receptors and
glucose transporters in the fetal cotyledonary (COT) and maternal
caruncular (CAR) tissues. In the CAR, mRNA expression of seven of
11 parameters was markedly reduced in FGR overnourished versus
control-intake pregnancies. Thus, values were reduced in FGR
versus Control groups for VEGFA (p ¼ 0.001), FLT1 (p ¼ 0.001), KDR
(p ¼ 0.003), ANGPT1 (p ¼ 0.007), ANGPT2 (p ¼ 0.023), SLC2A1
(p ¼ 0.004) and SLC2A3 (p ¼ 0.025). In general, values in the Non-
FGR overnourished group were intermediate and did not signiﬁ-
cantly differ from the Control group with the exception of SLC2A3,
which was expressed less (p ¼ 0.001). For ﬁve CAR parameters,
there was greater expression in Non-FGR versus FGR group: FLT1
(p ¼ 0.007); KDR (p ¼ 0.042); ANGPT1 (p ¼ 0.003); ANGPT2
(p ¼ 0.005); and SLC2A1 (p ¼ 0.003). By contrast, there were no
signiﬁcant differences in the COT with the exception of ANGPT2,
expression of which was greater in both FGR/non-FGR over-
nourished groups relative to controls (p ¼ 0.031/p ¼ 0.003).
4.4. Placental vascularity/proliferation
Fig. 3 details COT/CAR placental vascular indices following im-
age analysis of immunostained whole placentomes. Placental
vascularity data could not be reliably obtained for 2/12 and 1/10
animals in Control and Non-FGR groups, respectively. There were
no signiﬁcant differences in any CAR indices, however three COT
indices were affected by dietary intake. Irrespective of FGR status,
relative to controls, overnourished pregnancies exhibited increased
capillary area density (0.14 ± 0.018 vs. 0.08 ± 0.014, p ¼ 0.017),
capillary surface density (61.2 ± 6.21 vs. 42.2 ± 5.90 mm1,
p ¼ 0.035) and area per capillary (53.0 ± 4.80 vs. 34.8 ± 4.86 mm2,,
p ¼ 0.037). Values were highest in the Non-FGR group, were all
signiﬁcantly greater than the Control group (p ¼ 0.019, p ¼ 0.028
and p ¼ 0.014 for CAD, CSD and APC, respectively) and were in-
termediate in the FGR group. There were no differences between
Control, Non-FGR and FGR groups in proliferation index in the CAR
(1.6 ± 0.53, 2.9 ± 0.65 and 3.0 ± 0.94%; p¼ 0.491) or COT (6.5 ± 1.40,
9.8 ± 2.78 and 8.7 ± 1.03%; p ¼ 0.416).
5. Discussion
In this study, overnourishing pregnant adolescent ewes pro-
duced FGR, deﬁned as birthweight >2SD below that of normally-
grown control-fed adolescent ewes in 63% of pregnancies [5,25],
whilst fetal growth was relatively unperturbed in the remaining
(non-FGR) overnourished pregnancies. Accordingly, mean fetal
Fig. 1. Representative images of immunoﬂuorescence staining of whole placentomes. Representative photomicrograph of section of whole placentome triple stained for
vascularity, fetal trophoblast and cell nuclei [upper left] sampled from adolescent sheep dams at 131 ± 0.3 days gestation. Magniﬁcation ¼ x200. [upper right] Bright green selection
demonstrating fetal portion of placentome (cotyledon) based on lectin FITC staining, [middle right] fetal trophoblast circumscribed with ImagePro Premier software for determining
fetal (cotyledon) and maternal (caruncle) compartments. [middle left] CD31 staining (magenta) revealing all blood vessels within placentome. [lower left] blood vessels highlighted
(red) within maternal portion of placentome for quantiﬁcation. [lower right] blood vessels highlighted (red) within fetal portion of the placentome for quantiﬁcation.
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but not in the Non-FGR group. By contrast, total placental weight
was signiﬁcantly reduced in both FGR and Non-FGR overnourished
pregnancies (by 37% and 22%, respectively) and overnourishment
was associatedwith higher fetal:placental weight ratios, suggesting
increased placental efﬁciency, irrespective of FGR status. A previous
study found that ~20% of ovine placentomes had to be ablated mid-
gestation to signiﬁcantly perturb fetal growth in late gestation [26]
and our ﬁndings closely support this estimate of the functionalreserve capacity of the sheep placenta. The key role of the placenta
in the establishment of FGR in this paradigm is reinforced by strong
correlations between fetal and placental weights. However, given
the equivalent fetal:placental weight ratios in FGR and Non-FGR
overnourished groups, placental mass alone does not completely
explain the differential in fetal growth. There is a need to consider
other aspects of placental structure/function to explain the het-
erogeneous response to overnourishment of pregnant adolescent
ewes.
Table 1
Fetal/placental biometry and umbilical artery Doppler measurements in late gestation.
Parameter Control (n ¼ 12) Non-FGR (n ¼ 10) FGR (n ¼ 17) P Value
Biparietal diameter (mm) 54.7 ± 0.29a 53.9 ± 0.76ab 52.5 ± 0.43b 0.004
Abdominal circumference (mm) 286 ± 2.4a 270 ± 4.4b 259 ± 2.6c <0.001
Femur length (mm) 59.7 ± 1.17a 59.3 ± 1.2a 54.4 ± 0.69b <0.001
Tibia length (mm) 77.4 ± 1.07a 76.4 ± 1.23a 72.8 ± 1.11b 0.012
Renal volume (cm3) 10.0 ± 0.35a 8.8 ± 0.51b 7.7 ± 0.20c <0.001
Placentome index (cm2) 3.7 ± 0.18a 2.9 ± 0.25b 2.6 ± 0.18b 0.001
Umbilical cord diameter (mm) 22.9 ± 0.42a 21.3 ± 0.59b 19.9 ± 0.19c <0.001
Umbilical artery pulsatility index 0.89 ± 0.04a 1.12 ± 0.05b 1.05 ± 0.03b <0.001
Umbilical artery resistance index 0.59 ± 0.01a 0.66 ± 0.02b 0.65 ± 0.01b 0.001
Umbilical artery systolic to diastolic ratio 2.28 ± 0.16a 3.04 ± 0.15b 2.80 ± 0.09b 0.001
P values shown are for overall ANOVA. Mean values within a row with unlike superscripts are signiﬁcantly different (p < 0.05 for individual post-hoc comparisons). Data are
presented as mean ± SEM.
Table 2
Pregnancy outcome data from necropsy in late gestation.
Parameter Control (n ¼ 12) Non-FGR (n ¼ 10) FGR (n ¼ 17) P Value
Fetal weight (g) 5084 ± 124a 4824 ± 208a 3640 ± 117b <0.001
Placentome number 113 ± 5.2a 107 ± 3.7a 93 ± 4.0b 0.005
Total placentome weight (g) 521 ± 23.8a 406 ± 26.9b 330 ± 23.8c <0.001
Average placentome weight (g) 4.7 ± 0.21a 3.8 ± 0.22b 3.6 ± 0.21b 0.002
Membrane weight (g) 281 ± 15.9a 255 ± 14.9a 206 ± 10.6b 0.001
Total placental weight (g) 802 ± 36.1a 661 ± 40.1b 536 ± 32.8c <0.001
Placentome size
% <1 cm 18.3 ± 2.21 16.0 ± 1.5 18.9 ± 2.8 0.728
% 1e2 cm 16.5 ± 3.0a 23.6 ± 4.0ab 25.2 ± 2.0b 0.050
% 2e5 cm 62.0 ± 3.0 58.9 ± 4.6 54.6 ± 3.7 0.367
% >5 cm 3.1 ± 0.8 1.4 ± 0.6 1.3 ± 0.6 0.114
Placentome type
% A type 33.8 ± 8.9 36.7 ± 7.3 55.4 ± 7.5 0.109
% B type 39.8 ± 5.7 40.8 ± 5.9 33.2 ± 6.1 0.621
% C type 11.4 ± 3.1 5.2 ± 3.8 5.5 ± 2.1 0.251
% D type 15.2 ± 3.8 17.8 ± 9.2 6.2 ± 2.5 0.209
Placental efﬁciency (g fetus/g placenta) 9.9 ± 0.42a 12.1 ± 0.53b 11.7 ± 0.62b 0.033
Male-to-female fetal sex ratio 7:5 4:6 7:10 0.595
P values shown are for overall ANOVA with the single exception of the male-to-female sex ratio, for which the Chi square test was employed e bold indicates p < 0.05. Mean
values within a row with unlike superscripts are signiﬁcantly different (p < 0.05 for individual post-hoc comparisons). Data are presented as mean ± SEM.
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were greater in overnourished versus control-intake pregnancies.
This most likely reﬂected an adaptive response to the experimental
insult, aiming to maximise fetal nutrient supply during exponential
growth in late gestation. An increase in COT vascularity, presum-
ably also compensatory in nature, was previously observed at d90Fig. 2. Placentome types. Proportions of placentomes types A, B, C and D (according
to the classiﬁcation of Vatnick et al. [17]) sampled from 39 adolescent sheep dams at
131 ± 0.3 days gestation receiving a control intake (Control group, n ¼ 12) or a high
intake (overnourished, n ¼ 27) of the same complete diet to induce normal fetopla-
cental growth or placental and fetal growth restriction (FGR), respectively. Over-
nourished pregnancies were further subdivided into those subsequently deﬁned as
FGR, (fetal weight >2SD below Control group mean, n ¼ 17) or less perturbed with
relatively “normal” fetal weight (Non-FGR, n ¼ 10).in overnourished versus control-intake pregnancies but this dif-
ference did not persist to d130 [6]. Interestingly, previously it was
only the CND parameter that was impacted whereas the present
study revealed differences in CAD, CSD and APC but not CND.
Failure to detect differences in late-gestation CND may simply
reﬂect greater variability, as CND increases 10-fold from d50 to
d140 [27]. Alternatively it may indicate a drive towards dilatation of
existing blood vessels over angiogenesis. Irrespective, the obser-
vation that COT vascularity was greatest in the Non-FGR group is
novel and suggests that compensation at a vascular level is more
pronounced in pregnancies wherein fetal growth is preserved. By
means of deduction, vascular adaptation in the FGR group could be
considered suboptimal andmay underlie subsequent retardation of
fetal growth.
Despite no change in COT mRNA expression of most angiogenic
ligands/receptors, the patterns observed in vascularity were
mirrored by ANGPT2, which was upregulated by overnourishment
and greatest in the Non-FGR group. Placental ANGPT2 mRNA
expression is similarly upregulated in human FGR [28] and
hyperthermia-induced ovine FGR at d55 [29]. Moreover, in healthy
placental villous explants, hypoxia induces ANGPT2 expression [30],
which is strongly associated with vascular remodeling and facili-
tates angiogenic effects of VEGF and other factors [31,32]. Thus, COT
ANGPT2 may be a sensitive molecular marker of fetal placental
vascularity.
Notwithstanding shifts in vascularity and ANGPT2 expression,
ultrasonographic placentome/UA Doppler indices did not differ
Table 3
Maternal caruncular and fetal cotyledonary mRNA expression of angiogenic ligands/receptors and glucose transporters in late gestation placentomes.
Placental compartment and gene of interest Control (n ¼ 12) Non-FGR (n ¼ 10) FGR (n ¼ 17) P value
Maternal caruncle VEGFA 27.3 ± 3.04a 23.6 ± 7.45ab 18.3 ± 1.49b 0.014
FLT1 18.8 ± 2.26a 17.3 ± 5.46a 9.6 ± 1.13b 0.002
KDR 23.8 ± 2.40a 21.3 ± 6.72a 15.1 ± 1.40b 0.009
NOS3 28.6 ± 2.82 39.6 ± 12.52 29.9 ± 2.87 0.085
FGF2 15.7 ± 1.54 14.3 ± 4.51 11.5 ± 1.27 0.154
ANGPT1 24.0 ± 1.62a 25.2 ± 7.96a 17.1 ± 1.44b 0.004
ANGPT2 14.0 ± 1.17a 14.9 ± 4.72a 10.9 ± 0.70b 0.010
TEK 21.6 ± 2.63 20.2 ± 6.40 19.6 ± 1.76 0.785
GUCY1 16.5 ± 1.52 13.3 ± 4.20 13.8 ± 1.34 0.276
SLC2A1 18.6 ± 1.14a 19.0 ± 2.05a 13.3 ± 0.84b 0.003
SLC2A3 13.2 ± 0.81a 10.4 ± 0.89b 9.3 ± 0.68b 0.003
Fetal cotyledon VEGFA 26.5 ± 3.53 24.3 ± 7.69 34.7 ± 3.06 0.082
FLT1 15.1 ± 2.42 11.0 ± 3.48 16.7 ± 1.77 0.177
KDR 17.0 ± 2.44 13.5 ± 4.26 21.4 ± 2.12 0.096
NOS3 16.1 ± 2.17 15.4 ± 4.87 22.1 ± 2.56 0.075
FGF2 9.9 ± 1.07 11.6 ± 3.65 11.2 ± 0.86 0.510
ANGPT1 21.9 ± 1.64 23.9 ± 7.56 22.7 ± 0.90 0.654
ANGPT2 13.0 ± 0.79a 18.2 ± 5.76b 16.2 ± 0.92b 0.008
TEK 14.0 ± 0.79 15.5 ± 4.91 16.6 ± 0.73 0.101
GUCY1 8.9 ± 0.90 8.1 ± 2.56 8.5 ± 0.45 0.735
SLC2A1 22.9 ± 1.68 25.1 ± 1.57 23.7 ± 1.00 0.568
SLC2A3 20.7 ± 1.31 20.8 ± 1.00 21.6 ± 0.92 0.800
P values shown are for overall ANOVA e bold indicates p < 0.05. Mean values within a rowwith unlike superscripts are signiﬁcantly different (p < 0.05 for individual post-hoc
comparisons). Data are presented as mean ± SEM. Abbreviations: VEGFA ¼ vascular endothelial growth factor; FLT1 ¼ fms-related tyrosine kinase 1 (VEGF receptor 1),
KDR¼ kinase insert domain receptor (VEGF receptor 2); NOS3¼ nitric oxide synthase 3; FGF2¼ ﬁbroblast growth factor 2; ANGPT1¼ angiopoietin 1; ANGPT2¼ angiopoietin 2;
TEK ¼ endothelial tyrosine kinase; GUCY1 ¼ soluble guanylate cyclase (nitric oxide receptor); SLC2A1 ¼ solute carrier family 2 (facilitated glucose transporter) member 1;
SLC2A3 ¼ solute carrier family 2 (facilitated glucose transporter) member 3. All data presented are expressed relative to the housekeeping gene 18S.
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values in the Non-FGR group remained perturbed relative to
control-fed dams, despite relatively preserved fetal growth. The
only non-fetal ultrasound parameter to differ signiﬁcantly between
FGR and Non-FGR groups was UCD. Clinically, a lean umbilical cord
is a risk factor for adverse perinatal outcomes and reﬂects dimi-
nution of the Wharton's jelly and umbilical vein [33].
It can be challenging to separate cause and consequence in
uteroplacental FGR. Given the insidious nature of chronic utero-
placental insufﬁciency, there is usually time for adaptation to occur.
Fetal responses such as “brain sparing” are initiated by reduced
oxygen/nutrient supply [34]. Hypoxia triggers vascular remodelling
in the placenta [35] and numerous studies in this paradigm indicate
an early insult on uteroplacental development [6e12] preceding
the late-gestation reduction in placental mass. Switchover studies
in adolescent sheep suggest that high nutritional intakes exert their
strongest effects on pregnancy outcome in the middle third of
gestation [36]. Moreover, fetal growth cannot be “rescued” by
switching from high-to low-intake in the ﬁnal third of gestation,
once placental growth has been perturbed beyond the functional
reserve capacity of the organ [37]. Given that the primary utero-
placental insult due to overnourishment occurs in early to mid-
gestation, investigations in late gestation likely reﬂect both the
initial pathophysiology and adaptive processes during the second
half of pregnancy.
In the present study, there were no measurable changes in CAR
vascularity or cell proliferation. Nevertheless, there were major re-
ductions in several angiogenic ligands in FGR and/or Non-FGR
overnourished versus control-intake pregnancies, namely VEGF
and its receptors (FLT1/KDR) and both angiopoietins. mRNA
expression of all ﬁve parameters was lowest in the FGR group and
FLT1/KDR/ANGPT1/ANGPT2 expression was signiﬁcantly reduced
comparedwith theNon-FGR group, in keepingwith themore severe
phenotype. These likely represent stigmata of the primary utero-
placental insult, as there were no apparent compensatory responses
in the CAR. This agrees with our earlier study demonstrating
attenuated VEGFA/FLT1/ANGPT1/ANGPT2 and major reductions in
UBF mid-gestation in overnourished adolescent dams [7,11].Collectively, our ﬁndings suggest that the placenta has an
intrinsic reserve capacity that must be exceeded before FGR is
established. This may explain why nutrition must be radically
altered (e.g. famine) or applied to vulnerable groups (e.g. still-
growing adolescents) in order to signiﬁcantly perturb fetal
growth. For example, overnourishment of adult ewes of the same
genotype using the same diet as that provided to the adolescent
dams herein is not associated with any signiﬁcant perturbation of
fetal growth despite an increase in adiposity, suggesting that adult
sheep dams are relatively insensitive to overnutrition [38]. By
contrast, high intakes have been associated with FGR and/or fetal
programming effects in overnourished non-human primates, as
well as human maternal obesity and/or excessive gestational
weight gain [39,40]. In the present study, it was also notable that
relatively unperturbed fetuses also exhibited modiﬁed placental
vascularity. This is arguably more akin to late-onset FGR in humans,
wherein offspring may not be small-for-gestational-age and thus
remain clinically undetected. Despite birthweights within the
normal range, such individuals are at increased risk of adult-onset
disease [41], thus assessment of placental structure and/or function
is likely to be important, independently of fetal growth per se.
With respect to the effects of overnutrition on CAR indices, it
remains unknown precisely what nutritional signals might poten-
tially be read by the maternal placental tissues. The mammalian
target of rapamycin (mTOR) pathway, which is likely to play a
central role, can be stimulated or inhibited directly or indirectly by
circulating macronutrients, cortisol, adiponectin, IGF1, leptin or
insulin, or by changes in uteroplacental blood ﬂow [42], which may
explain how placental insufﬁciency can develop despite normal
nutrient availability. It is noteworthy that maternal concentrations
of glucose, insulin and IGF1 were greatest in the FGR overnourished
group in the present study, in support of this assumption. It also
remains unknown to what degree a potential shift in placentome
type may be important. In the present study, there was a trend
towards more A and less D type placentomes in the FGR group,
which may represent stigmata of failed adaptation, given that
evolution of A into D type placentomes is generally considered to be
a process aiming to maximise the surface area available for gaseous
Fig. 3. Maternal and fetal placental vascular indices at 131 days gestation. Placental vascular indices determined separately in maternal caruncle (CAR) and fetal cotyledon (COT)
following image analysis of immunostained sections of whole placentomes sampled from adolescent sheep dams at 131 ± 0.3 days gestation who received a control intake (Control
group, n ¼ 12) or a high intake (overnourished, n ¼ 27) of the same complete diet to induce normal fetoplacental growth or placental and fetal growth restriction (FGR),
respectively. Overnourished pregnancies were further subdivided into those subsequently deﬁned as FGR, (fetal weight >2SD below Control group mean, n ¼ 17) or less perturbed
with relatively “normal” fetal weight (Non-FGR, n ¼ 10). Data are presented as mean ± SEM. * indicates p < 0.05 for individual post-hoc comparisons (using test of least signiﬁcant
difference) following one-way analysis of variances. Abbreviations: CAD ¼ capillary area density; CND ¼ capillary number density; CSD ¼ capillary surface density; APC ¼ area per
capillary [see Methods for calculations].
D.J. Carr et al. / Placenta 46 (2016) 79e86 85exchange. In keeping with this theory, the proportion of A type
placentomes was negatively associated with CAR APC. Further-
more, the lack of signiﬁcant differences in placentome size or type
between Control and Non-FGR overnourished groups suggests that
the increased vascular parameters observed in the latter at a his-
tological level would not be expected to relate to the gross
assessment.
In summary, relative to control-intake sheep pregnancy, over-
nourished pregnancies are characterised by higher COT vascularity,
which likely represents a compensatory response to reduced
nutrient supply leading to enhanced placental efﬁciency. Relative to
overnourished pregnancies in which fetal growth is relatively
preserved, overnourished sheep pregnancies that culminate inmarked FGR have less placental vascularity suggesting incomplete
adaptation to the prenatal insult. In contrast, whilst CAR vascularity
is not signiﬁcantly impacted by nutritional manipulation, reduced
CAR mRNA expression of a panel of angiogenic ligands/receptors is
apparent in late gestation, consistent with a putative nutritionally-
mediated uteroplacental insult earlier in pregnancy.
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